Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 234

The DOI matches its Crossref record.

Double‐Blind Trial of Fluoxetine: Chronic Daily Headache and Migraine

Saper, Joel R., Silberstein, Stephen D., Lake, Alvin E., Winters, Marjorie E. · 1994 · Headache: The Journal of Head and Face Pain

Abstract

SYNOPSIS This study is the first double‐blind placebo‐controlled trial of fluoxetine for chronic daily headache (CDH) and migraine. After a one month single‐blind baseline on placebo, subjects with CDH (n=64) and migraine (n=58) were randomly assigned to a three month trial of fluoxetine (20 mg) or an identical placebo. Fluoxetine and placebo were increased to 40 mg in the second month, depending on patient response. Patients kept daily headache records, and completed 100 mm visual analogue scales (VAS) of headache and mood each month. For the group of CDH patients on fluoxetine, overall headache status (VAS) after three months compared to the end of the single‐blind placebo baseline improved a mean of 50% vs. 11% for those receiving the double‐blind placebo ( P =.029), with 47% vs. 23% improving at least 50% ( P =.097, n.s.). Fluoxetine patients showed significant improvement in monthly mood ratings compared to placebo (.001 by the end of the study), and modest but significant improvement in daily records of headache frequency ( P =.019) but not pain severity. Significant mood improvements preceded improvement in headache, reaching significance by the end of the second month on fluoxetine ( P =.013), while headache improvement emerged only during the third month ( P =.001). Double‐blind investigator judgement identified more headache improvement in fluoxetine than placebo recipients (40% vs. 22%, P =.032). Fluoxetine was not effective on any measure for migraine, with the exception of modest mood improvement at the end of the third month ( P =.043). Adverse effects were more frequent but not more severe for fluoxetine, including sleep disturbance (28% vs. 8%, P =.008), tremors (20% vs. 5%, P =.025), and minor stomach pain (13% vs. 0%, P =.008). Fluoxetine appears moderately effective for CDH but not migraine, with a generally tolerable side effect profile. The influence on headache may be linked to its effect on mood. In general, study subjects were not clinically depressed. Future research might focus on subjects with comorbid depression and headache.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1526-4610.1994.hed3409497.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 234

Metadata

Authors
Saper, J. R., Silberstein, S. D., Lake, A. E., & Winters, M. E.
Venue
Headache: The Journal of Head and Face Pain
Publisher
Wiley
Published
1994-10
Volume
34
Issue
9
Pages
497-502
ISSN
  • 0017-8748 (ISSN-L)
  • 1526-4610
OpenAlex
W1974101169
Cited by
234
References
0
FWCI
4.35
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Double‐Blind Trial of Fluoxetine: Chronic Daily Headache and Migraine. https://app.cochat.ai/papers/10.1111/j.1526-4610.1994.hed3409497.x
The paper
Saper, J. R., Silberstein, S. D., Lake, A. E., & Winters, M. E. (1994). Double‐Blind Trial of Fluoxetine: Chronic Daily Headache and Migraine. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.1994.hed3409497.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.